The homodimeric HIV-1 protease is the target of some of the most effective antiviral AIDS therapy, as it facilitates viral maturation by cleaving ten asymmetric and nonhomologous sequences in the Gag and Pol polyproteins. Since the specificity of this enzyme is not easily determined from the sequences of these cleavage sites alone, we solved the crystal structures of complexes of an inactive variant (D25N) of HIV-1 protease with six peptides that correspond to the natural substrate cleavage sites. When the protease binds to its substrate and buries nearly 1000 A2 of surface area, the symmetry of the protease is broken, yet most internal hydrogen bonds and waters are conserved. However, no substrate side chain hydrogen bond is conserved. Spe...
AbstractHIV-1 protease is a major drug target against AIDS as it permits viral maturation by process...
AbstractBackground: The HIV protease is essential for the life cycle of the virus and is an importan...
The effect of amino acid variability between human immunodeficiency virus type 1 (HIV-1) clades on s...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
The crystal structure of an actual HIV-1 protease-substrate complex is presented at 2.0 A resolution...
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
The rational design of drugs that can inhibit the action of viral proteases depends on obtaining acc...
HIV-1 protease is a major drug target against AIDS as it permits viral maturation by processing the ...
The HIV protease is an important drug target for HIV/AIDS therapy, and its structure and function ha...
AbstractHIV-1 protease is a major drug target against AIDS as it permits viral maturation by process...
HIV-1 protease (PR) permits viral maturation by processing the Gag and Gag-Pro-Pol polyproteins. Tho...
ABSTRACT: Strain is eliminated as a factor in hydrolysis of the scissile peptide bond by human immun...
AbstractHIV-1 protease is a major drug target against AIDS as it permits viral maturation by process...
AbstractBackground: The HIV protease is essential for the life cycle of the virus and is an importan...
The effect of amino acid variability between human immunodeficiency virus type 1 (HIV-1) clades on s...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
HIV-1 protease is a key target in treating HIV infection and AIDS, with 10 inhibitors used clinicall...
The crystal structure of an actual HIV-1 protease-substrate complex is presented at 2.0 A resolution...
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
The rational design of drugs that can inhibit the action of viral proteases depends on obtaining acc...
HIV-1 protease is a major drug target against AIDS as it permits viral maturation by processing the ...
The HIV protease is an important drug target for HIV/AIDS therapy, and its structure and function ha...
AbstractHIV-1 protease is a major drug target against AIDS as it permits viral maturation by process...
HIV-1 protease (PR) permits viral maturation by processing the Gag and Gag-Pro-Pol polyproteins. Tho...
ABSTRACT: Strain is eliminated as a factor in hydrolysis of the scissile peptide bond by human immun...
AbstractHIV-1 protease is a major drug target against AIDS as it permits viral maturation by process...
AbstractBackground: The HIV protease is essential for the life cycle of the virus and is an importan...
The effect of amino acid variability between human immunodeficiency virus type 1 (HIV-1) clades on s...